Details for New Drug Application (NDA): 202931
✉ Email this page to a colleague
The generic ingredient in FROVATRIPTAN SUCCINATE is frovatriptan succinate. There are three drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the frovatriptan succinate profile page.
Summary for 202931
Tradename: | FROVATRIPTAN SUCCINATE |
Applicant: | Mylan |
Ingredient: | frovatriptan succinate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 2.5MG BASE | ||||
Approval Date: | Aug 28, 2014 | TE: | RLD: | No |
Complete Access Available with Subscription